Seva Katritch(@sevakat1) 's Twitter Profileg
Seva Katritch

@sevakat1

ID:893282758151225345

linkhttp://katritch.usc.edu calendar_today04-08-2017 01:29:40

467 Tweets

627 Followers

90 Following

Seva Katritch(@sevakat1) 's Twitter Profile Photo

Amazing tour de force, Jordy Homing Lam! The first comprehensive NMA algorithm to work on NVIDIA GPUs with >250 acceleration and scalable to 20M atoms. Utility in many apps, e.g. capturing dynamics in cryoEM/cryoET.

account_circle
Seva Katritch(@sevakat1) 's Twitter Profile Photo

The INCHING paper is not even out yet (hopefully this week...), but Jordy Homing Lam is already receiving accolades for it. He won the highly competitive Chemical Computing Group Excellence Award and will give a talk at Fall 2024 ACS national meeting! Congratulations Jordy!

account_circle
Seva Katritch(@sevakat1) 's Twitter Profile Photo

An exciting collaboration with Fokin Lab USC , BryanRoth and ALex Makriyannis labs showing how a single super scaffold can dramatically expand on-demand virtual screening space and yield great hits and lead compounds.

An exciting collaboration with @FokinLabUSC , @zenbrainest and ALex Makriyannis labs showing how a single super scaffold can dramatically expand on-demand virtual screening space and yield great hits and lead compounds.
account_circle
Seva Katritch(@sevakat1) 's Twitter Profile Photo

Virtual Screening of a Chemically Diverse “Superscaffold” Library Enables Ligand Discovery for a Key GPCR Target | ACS Chemical Biology pubs-acs-org.libproxy2.usc.edu/doi/full/10.10…

account_circle
Matthieu Schapira(@mattschap) 's Twitter Profile Photo

Preliminary results for CACHE #4 are out: 1688 compounds predicted by 23 participants to bind the TKB domain of CBLB were tested. 10 bind CBLB and not an unrelated target. 9 participants advance to Round 2: hit expansion. bit.ly/3vOCFKB Structural Genomics Consortium (SGC) Conscience

Preliminary results for CACHE #4 are out: 1688 compounds predicted by 23 participants to bind the TKB domain of CBLB were tested. 10 bind CBLB and not an unrelated target. 9 participants advance to Round 2: hit expansion. bit.ly/3vOCFKB @thesgconline @consciencemeds
account_circle
Eric Topol(@EricTopol) 's Twitter Profile Photo

This drug class is exceeding all expectations, well beyond weight loss, with new clinical trial data this week for heart disease and
A rundown and where we're headed in the new Ground Truths (link in profile) and a companion podcast w/ Daniel J Drucker

This drug class is exceeding all expectations, well beyond weight loss, with new clinical trial data this week for heart disease and #Parkinsons A rundown and where we're headed in the new Ground Truths (link in profile) and a companion podcast w/ @DanielJDrucker
account_circle
Nature Reviews Drug Discovery(@NatRevDrugDisc) 's Twitter Profile Photo

Novel drug targets in 2023 bit.ly/3VLYwwP

The new drugs approved last year included agents with 12 targets not previously modulated by approved drugs, such as the neurokinin 3 receptor, complement factor B and SOD1. Find out more in this article from DruggableGenome

Novel drug targets in 2023 bit.ly/3VLYwwP The new drugs approved last year included agents with 12 targets not previously modulated by approved drugs, such as the neurokinin 3 receptor, complement factor B and SOD1. Find out more in this article from @DruggableGenome
account_circle
Eric Topol(@EricTopol) 's Twitter Profile Photo

Thanks to generative , a drug that counters fibrosis (scarring), and possibly modulates the tissue aging process, with its mechanism elucidated, has been rapidly advanced to clinical trials for IPF
nature.com/articles/s4158…
Nature Biotechnology Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs) Insilico Medicine

account_circle
Seva Katritch(@sevakat1) 's Twitter Profile Photo

Enjoying the visit by AI-in-Chemistry wizard Olexandr Isayev 🇺🇦🇺🇸 Isayev and his talk for the ChemBio/CNT3D joint seminar. Please also join us for the Drug Discovery Innovation Workshop tomorrow, where Oles gives another talk tinyurl.com/DDIWork

Enjoying the visit by AI-in-Chemistry wizard @olexandr Isayev and his talk for the ChemBio/CNT3D joint seminar. Please also join us for the Drug Discovery Innovation Workshop tomorrow, where Oles gives another talk tinyurl.com/DDIWork
account_circle
Seva Katritch(@sevakat1) 's Twitter Profile Photo

Please join us for DDI Workshop at USC, MCB-101/102 on Feb 23rd, for talks from leaders in drug discovery from USC, UCSF, CMU, UCI + pharma, discussion panel, and networking at lunch, posters and reception.
Details: tinyurl.com/DDIWork
RSVP: tinyurl.com/DDIRSVP
Pls RT

account_circle
Enamine Ltd 🇺🇦(@EnamineLtd) 's Twitter Profile Photo

Full catalogs of Enamine MADE Building Blocks and Enamine REAL compounds are all searchable at chem-space.com/search.
Many thanks to our partners from Chemspace for their valuable contribution!

account_circle
Cornelius Gati(@CorneliusGati) 's Twitter Profile Photo

In light of the recent avalanche of VMAT2 structures, Ravi Yadav and I wrote a 'Research Highlight': Packaging monoamine neurotransmitters. Out in Cell Research. rdcu.be/dwp8Z

account_circle
Matthieu Schapira(@mattschap) 's Twitter Profile Photo

CACHE#1 results are in: bit.ly/48zjBhI. No prior ligand for the target. 1955 compounds predicted by 23 experts. 7 convincingly confirmed experimentally. This is the state-of-the-art. Exploration of modern AI techniques in 6 of the 7 top performing methods.

CACHE#1 results are in: bit.ly/48zjBhI. No prior ligand for the target. 1955 compounds predicted by 23 experts. 7 convincingly confirmed experimentally. This is the state-of-the-art. Exploration of modern AI techniques in 6 of the 7 top performing methods. #compchem
account_circle
BryanRoth(@zenbrainest) 's Twitter Profile Photo

In our latest paper we discover, literally, 100's of thousands of new 5-HT2A chemotypes as potentially structural novel psychedelics

biorxiv.org/content/10.110…

In our latest paper we discover, literally, 100's of thousands of new 5-HT2A chemotypes as potentially structural novel psychedelics #psychdelics biorxiv.org/content/10.110…
account_circle
drug hunter(@drughuntersite) 's Twitter Profile Photo

2023 Novel Small Molecule FDA Drug Approvals

Full article, high-resolution PDF, and more details: drughunters.com/4aS31en

account_circle
Exscientia(@exscientiaAI) 's Twitter Profile Photo

And also introducing PhysicsML - a package for physics-based/related models, providing a freely available, standardised and modular interface for handling, building and training 3d models with an emphasis on . Find out more: exscientia.github.io/physicsml/

And also introducing PhysicsML - a package for physics-based/related models, providing a freely available, standardised and modular interface for handling, building and training 3d models with an emphasis on #neuralnetpotentials. Find out more: exscientia.github.io/physicsml/
account_circle